Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels - PubMed (original) (raw)
Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels
Wai-man R Wong et al. Circ Res. 2003.
Abstract
The impact of common variants in the apolipoprotein gene cluster (APOC3-A4-A5) on prospective coronary heart disease (CHD) risk was examined in healthy UK men. Of the 2808 men followed over 9 years, 187 had a clinically defined CHD event. Examination of 9 single nucleotide polymorphisms (SNPs) in this group revealed that homozygotes for APOA4 S347 had significantly increased risk of CHD [hazard ratio (HR) of 2.07 (95%CI 1.04 to 4.12)], whereas men homozygous for APOC3 1100T were protected [HR 0.28 (95%CI 0.09 to 0.87)]. In stepwise multiple regression analysis, after entering all the variants and adjusting for established risk factors APOA4 T347S alone remained in the model. Using all nine SNPs, the highest risk-estimate haplotypes carried APOA4 S347 and rare alleles of the two flanking intergenic markers. The protective effect of APOC3 1100T could be explained by negative linkage disequilibrium with these alleles. To determine the association of APOA4 T347S with apoAIV levels, the relationship was examined in 1600 healthy young European men and women. S347 homozygotes had significantly lower apoAIV plasma levels (13.64+/-0.59 mg/dL) compared with carriers of the T347 allele (14.90+/-0.12 mg/dL) (P=0.035). These results demonstrate that genetic variation in and around APOA4, independent of the effects of triglyceride, is associated with risk of CHD and apoAIV levels, supporting an antiatherogenic role for apoAIV.
Similar articles
- Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.
Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, Rubin EM, Pennacchio LA, Humphries SE. Talmud PJ, et al. Hum Mol Genet. 2002 Nov 15;11(24):3039-46. doi: 10.1093/hmg/11.24.3039. Hum Mol Genet. 2002. PMID: 12417525 - Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
Dallongeville J, Cottel D, Montaye M, Codron V, Amouyel P, Helbecque N. Dallongeville J, et al. Int J Cardiol. 2006 Jan 13;106(2):152-6. doi: 10.1016/j.ijcard.2004.10.065. Int J Cardiol. 2006. PMID: 16321685 - Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM, Srinivasan SR, Chen W, Boerwinkle E, Berenson GS. Hallman DM, et al. Metabolism. 2006 Dec;55(12):1574-81. doi: 10.1016/j.metabol.2006.07.018. Metabolism. 2006. PMID: 17142127 - [A novel gene in APOA1/C3/A4/A5 cluster: apolipoprotein A5].
Liu HK, Zhang SZ, Su ZG, Ma YX, Wang CT. Liu HK, et al. Yi Chuan. 2004 Nov;26(6):953-6. Yi Chuan. 2004. PMID: 15640132 Review. Chinese. - Genetic epidemiological studies of coronary heart disease.
Keavney B. Keavney B. Int J Epidemiol. 2002 Aug;31(4):730-6. doi: 10.1093/ije/31.4.730. Int J Epidemiol. 2002. PMID: 12177010 Review. No abstract available.
Cited by
- A Multiplexed Quantitative Proteomics Approach to the Human Plasma Protein Signature.
Núñez E, Gómez-Serrano M, Calvo E, Bonzon-Kulichenko E, Trevisan-Herraz M, Rodríguez JM, García-Marqués F, Magni R, Lara-Pezzi E, Martín-Ventura JL, Camafeita E, Vázquez J. Núñez E, et al. Biomedicines. 2024 Sep 18;12(9):2118. doi: 10.3390/biomedicines12092118. Biomedicines. 2024. PMID: 39335631 Free PMC article. - Closing the gaps in patient management of dyslipidemia: stepping into cardiovascular precision diagnostics with apolipoprotein profiling.
Reijnders E, van der Laarse A, Ruhaak LR, Cobbaert CM. Reijnders E, et al. Clin Proteomics. 2024 Mar 1;21(1):19. doi: 10.1186/s12014-024-09465-w. Clin Proteomics. 2024. PMID: 38429638 Free PMC article. Review. - Association of rs662799 variant and APOA5 gene haplotypes with metabolic syndrome and its components: a meta-analysis in North Africa.
Hechmi M, Dallali H, Gharbi M, Jmel H, Fassatoui M, Ben Halima Y, Bahri S, Bahlous A, Abid A, Jamoussi H, Barakat A, Kefi R. Hechmi M, et al. Biosci Rep. 2020 Aug 28;40(8):BSR20200706. doi: 10.1042/BSR20200706. Biosci Rep. 2020. PMID: 32725151 Free PMC article. Review. - Regulation of intestinal lipid metabolism: current concepts and relevance to disease.
Ko CW, Qu J, Black DD, Tso P. Ko CW, et al. Nat Rev Gastroenterol Hepatol. 2020 Mar;17(3):169-183. doi: 10.1038/s41575-019-0250-7. Epub 2020 Feb 3. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32015520 Review. - Apolipoprotein A-IV acts as an endogenous anti-inflammatory protein and is reduced in treatment-naïve allergic patients and allergen-challenged mice.
Roula D, Theiler A, Luschnig P, Sturm GJ, Tomazic PV, Marsche G, Heinemann A, Sturm EM. Roula D, et al. Allergy. 2020 Feb;75(2):392-402. doi: 10.1111/all.14022. Epub 2019 Sep 10. Allergy. 2020. PMID: 31408538 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous